Influence of smoking on serum and milk of mothers, and their infants' serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels

被引:6
作者
Ermis, B [1 ]
Altinkaynak, K
Yildirim, A
Ozkan, B
机构
[1] Zonguldak Karaelmas Univ, Sch Med, Dept Pediat, Div Neonatol, TR-67600 Kozlu, Zonguldak, Turkey
[2] Nenehatun Obstet & Gynecol Hosp, Dept Biochem, Erzurum, Turkey
[3] Ataturk Univ, Sch Med, Dept Biochem, Erzurum, Turkey
[4] Ataturk Univ, Sch Med, Dept Pediat, Erzurum, Turkey
关键词
smoking; pregnancy; milk; human; insulin-like growth factor-I; insulin-like growth factor binding protein-3;
D O I
10.1159/000081974
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate the serum and milk in active-smoking and nonsmoking mothers, and their infants' insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) levels. Design and Setting: A cohort study conducted at a tertiary medical center. Subjects: Forty-four mothers (age range: 21-34 years) and their newborns (7 days old) were enrolled in the study. Mothers were interviewed and classified according to their smoking status into one of two groups: the active-smoking mothers (n = 21) and the nonsmoking mothers (n = 23). Results: There was no difference noted in either IGF-I, IGFBP-3 or IGF-I/IGFBP-3 ratios in serum and milk of mothers, and their infants' serum samples according to maternal smoking. Conclusion: This study demonstrated that maternal smoking (5-10 cigarettes/day) did not influence the maternal and infant serum levels of IGF-I and IGFBP-3 as well as the breast milk levels of these peptides. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:288 / 292
页数:5
相关论文
共 30 条
[1]   Serum IGF-I and IGFBP-3 in healthy pregnancies and patients with preeclampsia [J].
Altinkaynak, K ;
Aksoy, H ;
Bakan, E ;
Kumtepe, Y .
CLINICAL BIOCHEMISTRY, 2003, 36 (03) :221-223
[2]  
Amir Lisa Helen, 2003, Breastfeed Rev, V11, P19
[3]  
[Anonymous], 1992, RESP HLTH EFF PASS S
[4]   INSULIN-LIKE GROWTH-FACTORS (IGF)-1 AND (IGF)-2 IN HUMAN-FETAL PLASMA AND RELATIONSHIP TO GESTATIONAL-AGE AND FETAL SIZE DURING MIDPREGNANCY [J].
ASHTON, IK ;
ZAPF, J ;
EINSCHENK, I ;
MACKENZIE, IZ .
ACTA ENDOCRINOLOGICA, 1985, 110 (04) :558-563
[5]   IMMUNOREACTIVE SOMATOMEDIN-C INSULIN-LIKE GROWTH FACTOR-I AND ITS BINDING-PROTEIN IN HUMAN-MILK [J].
BAXTER, RC ;
ZALTSMAN, Z ;
TURTLE, JR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (06) :955-959
[6]   PROLACTIN, GROWTH-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I IN NEWBORN CHILDREN OF SMOKING MOTHERS [J].
BERATIS, NG ;
VARVARIGOU, A ;
MAKRI, M ;
VAGENAKIS, AG .
CLINICAL ENDOCRINOLOGY, 1994, 40 (02) :179-185
[7]   INSULIN-LIKE GROWTH FACTOR-I (IGF-I)-BINDING PROTEIN COMPLEX IS A BETTER MITOGEN THAN FREE IGF-I [J].
BLUM, WF ;
JENNE, EW ;
REPPIN, F ;
KIETZMANN, K ;
RANKE, MB ;
BIERICH, JR .
ENDOCRINOLOGY, 1989, 125 (02) :766-772
[8]  
CHARD T, 1994, GROWTH REGULAT, V4, P91
[9]  
CLEMMONS DR, 1992, GROWTH REGULAT, V2, P80
[10]  
COUNTANT R, 2001, J CLIN ENDOCR METAB, V86, P4854